Health Care & Life Sciences » Pharmaceuticals | Kissei Pharmaceutical Co. Ltd.

Kissei Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
58,314
52,373
50,142
48,148
47,659
49,364
Total Accounts Receivable
23,711
23,675
24,966
24,730
28,872
26,962
Inventories
12,812
14,646
17,375
16,724
15,932
13,963
Other Current Assets
6,057
6,667
7,568
7,612
8,134
5,491
Total Current Assets
100,894
97,361
100,051
97,218
100,599
95,782
Net Property, Plant & Equipment
26,960
26,852
26,758
26,308
26,396
25,503
Total Investments and Advances
41,617
54,355
62,310
58,291
81,194
86,958
Long-Term Note Receivable
137
134
115
119
44
68
Intangible Assets
692
785
813
1,845
1,716
1,519
Other Assets
1,783
1,566
2,745
2,499
2,634
3,045
Total Assets
172,649
181,484
193,345
186,801
213,087
213,522
ST Debt & Current Portion LT Debt
1,933
1,879
1,880
1,844
1,836
Accounts Payable
5,390
6,045
5,829
4,849
4,894
Income Tax Payable
3,231
1,372
1,668
1,055
2,375
Other Current Liabilities
7,325
9,638
10,231
7,908
8,343
Total Current Liabilities
17,879
18,934
19,608
15,656
17,448
Long-Term Debt
1,604
1,616
1,591
1,732
2,097
Provision for Risks & Charges
6,034
2,500
6,249
5,625
4,888
Deferred Taxes
3,251
6,907
6,842
5,128
11,701
Other Liabilities
494
376
377
357
356
Total Liabilities
29,828
30,764
35,220
29,015
36,990
Common Equity (Total)
142,590
150,441
157,860
157,454
175,702
Total Shareholders' Equity
142,590
150,441
157,860
157,454
175,702
Total Equity
142,821
150,720
158,125
157,783
176,092
Liabilities & Shareholders' Equity
172,649
181,484
193,345
186,798
213,082
Accumulated Minority Interest
231
279
265
329
390

About Kissei Pharmaceutical Co.

View Profile
Address
19-48 Yoshino
Matsumoto 399
Japan
Employees -
Website http://www.kissei.co.jp
Updated 07/08/2019
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Ethical Pharmaceuticals and Others. The Ethical Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism.